|
1
|
Chan AT: Nasopharyngeal carcinoma. Ann
Oncol. 21 Suppl 7:i308–i312. 2010. View Article : Google Scholar
|
|
2
|
Chua DT, Sham JS and Au GK: A phase II
study of docetaxel and cisplatin as first-line chemotherapy in
patients with metastatic nasopharyngeal carcinoma. Oral Oncol.
41:589–595. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galluzzi L, Vitale I, Michels J, Brenner
C, Szabadkai G, Harel-Bellan A, Castedo M and Kroemer G: Systems
biology of cisplatin resistance: Past, present and future. Cell
Death Dis. 5:e12572014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galluzzi L, Pietrocola F, Bravo-San Pedro
JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J,
Gewirtz DA, Karantza V, et al: Autophagy in malignant
transformation and cancer progression. Embo J. 7:856–880. 2015.
View Article : Google Scholar
|
|
5
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun K, Deng W, Zhang S, Cai N, Jiao S,
Song J and Wei L: Paradoxical roles of autophagy in different
stages of tumorigenesis: Protector for normal or cancer cells. Cell
Biosci. 3:352013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Klionsky DJ, Abdalla FC, Abeliovich H,
Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M,
Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy. Autophagy.
8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu
LZ and Jiang BH: Downregulation of ATG14 by EGR1-MIR152 sensitizes
ovarian cancer cells to cisplatin-induced apoptosis by inhibiting
cyto-protective autophagy. Autophagy. 11:373–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hashimoto D, Bläuer M, Hirota M, Ikonen
NH, Sand J and Laukkarinen J: Autophagy is needed for the growth of
pancreatic adenocarcinoma and has a cytoprotective effect against
anticancer drugs. Eur J Cancer. 50:1382–1390. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cufi S, Vazquez-Martin A,
Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, López-Bonet E,
Martin-Castillo B, Joven J and Menendez JA: The anti-malarial
chloroquine overcomes primary resistance and restores sensitivity
to trastuzumab in HER2-positive breast cancer. Sci Rep. 3:24692013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fulda S and Kögel D: Cell death by
autophagy: Emerging molecular mechanisms and implications for
cancer therapy. Oncogene. 34:5105–5113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu YL, Yang PM, Shun CT, Wu MS, Weng JR
and Chen CC: Autophagy potentiates the anti-cancer effects of the
histone deacetylase inhibitors in hepatocellular carcinoma.
Autophagy. 6:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salazar M, Carracedo A, Salanueva IJ,
Hernández-Tiedra S, Lorente M, Egia A, Vázquez P, Blázquez C,
Torres S, García S, et al: Cannabinoid action induces
autophagy-mediated cell death through stimulation of ER stress in
human glioma cells. J Clin Invest. 119:1359–1372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dave B, Mittal V, Tan NM and Chang JC:
Epithelial-mesenchymal transition, cancer stem cells and treatment
resistance. Breast Cancer Res. 14:2022012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Micalizzi DS and Ford HL:
Epithelial-mesenchymal transition in development and cancer. Future
Oncol. 5:1129–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu X, Shen H, Yin X, Long L, Xie C, Liu
Y, Hui L, Lin X, Fang Y, Cao Y, et al: miR-186 regulation of Twist1
and ovarian cancer sensitivity to cisplatin. Oncogene. 35:323–332.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Catalano M, D'Alessandro G, Lepore F,
Corazzari M, Caldarola S, Valacca C, Faienza F, Esposito V,
Limatola C, Cecconi F and Di Bartolomeo S: Autophagy induction
impairs migration and invasion by reversing EMT in glioblastoma
cells. Mol Oncol. 9:1612–1625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nantajit D, Lin D and Li JJ: The network
of epithelial-mesenchymal transition: Potential new targets for
tumor resistance. J Cancer Res Clin Oncol. 141:1697–1713. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akalay I, Janji B, Hasmim M, Noman MZ,
André F, de Cremoux P, Bertheau P, Badoual C, Vielh P, Larsen AK,
et al: Epithelial-to-mesenchymal transition and autophagy induction
in breast carcinoma promote escape from T-cell-mediated lysis.
Cancer Res. 73:2418–2427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Z, Zhang L, Xie B, Wang X, Yang X,
Ding N, Zhang J, Liu Q, Tan G, Feng D and Sun LQ: FOXC2 promotes
chemoresistance in nasopharyngeal carcinomas via induction of
epithelial mesenchymal transition. Cancer Lett. 363:137–145. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang P, Liu H, Xia F, Zhang QW, Zhang YY,
Zhao Q, Chao ZH, Jiang ZW and Jiang CC: Epithelial-mesenchymal
transition is necessary for acquired resistance to cisplatin and
increases the metastatic potential of nasopharyngeal carcinoma
cells. Int J Mol Med. 33:151–159. 2014.PubMed/NCBI
|
|
25
|
Thorburn A, Thamm DH and Gustafson DL:
Autophagy and cancer therapy. Mol Pharmacol. 85:830–838. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song L, Liu H, Ma L, Zhang X, Jiang Z and
Jiang C: Inhibition of autophagy by 3-MA enhances endoplasmic
reticulum stress-induced apoptosis in human nasopharyngeal
carcinoma cells. Oncol Lett. 6:1031–1038. 2013.PubMed/NCBI
|
|
27
|
Talbot LJ, Bhattacharya SD and Kuo PC:
Epithelial-mesenchymal transition, the tumor microenvironment and
metastatic behavior of epithelial malignancies. Int J Biochem Mol
Biol. 3:117–136. 2012.PubMed/NCBI
|
|
28
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: A cancer researcher's conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kiyono K, Suzuki HI, Matsuyama H,
Morishita Y, Komuro A, Kano MR, Sugimoto K and Miyazono K:
Autophagy is activated by TGF-beta and potentiates
TGF-beta-mediated growth inhibition in human hepatocellular
carcinoma cells. Cancer Res. 69:8844–8852. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Suzuki HI, Kiyono K and Miyazono K:
Regulation of autophagy by transforming growth factor-β (TGF-β)
signaling. Autophagy. 6:645–647. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mikaelian I, Malek M, Gadet R, Viallet J,
Garcia A, Girard-Gagnepain A, Hesling C, Gillet G, Gonzalo P,
Rimokh R and Billaud M: Genetic and pharmacologic inhibition of
mTORC1 promotes EMT by a TGF-β-independent mechanism. Cancer Res.
73:6621–6631. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes
is associated with activation of the PI3K/Akt/mTOR pathway in
prostate cancer radioresistance. Cell Death Dis. 4:e8752013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lv Q, Wang W, Xue J, Hua F, Mu R, Lin H,
Yan J, Lv X, Chen X and Hu ZW: DEDD interacts with PI3KC3 to
activate autophagy and attenuate epithelial-mesenchymal transition
in human breast cancer. Cancer Res. 72:3238–3250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo
Y, Song Z, Zheng Q and Xiong J: Autophagy promotes hepatocellular
carcinoma cell invasion through activation of
epithelial-mesenchymal transition. Carcinogenesis. 34:1343–1351.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cufi S, Vazquez-Martin A,
Oliveras-Ferraros C, Martin-Castillo B, Vellon L and Menendez JA:
Autophagy positively regulates the CD44(+) CD24(−/low) breast
cancer stem-like phenotype. Cell Cycle. 10:3871–3885. 2011.
View Article : Google Scholar : PubMed/NCBI
|
